We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 87.860.0%Oct 23 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Renmanco4/27/2018 3:12:30 PM
5 Recommendations

Recommended By

   of 59561
Hiring a skilled pricing specialist is a smart move at this time. Drugs are priced very differently depending upon the distribution channel, including geographies being considered. Being able to justify a price is critical as the company moves forward with commercialization activities....and the best time to establish expected prices that can be charged is well in advance of the day that approval is granted so that the company can roll out its products in the higher ROI markets before having to confront less profitable venues.
As the best possible distribution channels can be defined, it will affect hiring of regional sales managers, reps, etc so that the company can target those with the most experience in the markets expected to be developed first.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext